Comparative Study of Olopatadine Hydrochloride 0.1% and Emedastine difumarate 0.05% Comparing their Clinical Efficacy and Adverse Effects in Allergic Conjunctivitis. Medical Forum Monthly, [S. l.], v. 26, n. 5, 2024. Disponível em: https://medicalforummonthly.com/index.php/mfm/article/view/2774.. Acesso em: 17 nov. 2025.